Home › Funds › Royal Fund Management, LLC › CVS

Royal Fund Management, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

Royal Fund Management, LLC reported holding 86,465 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 0.68% of its reported portfolio and ranking #46 among its reported holdings. Royal Fund Management, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)86.47K sh
Reported value held$7.41M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Royal Fund Management, LLC's CVS position evolved

Royal Fund Management, LLC first disclosed a stake in CVS in Q3 2023 at 78,700 shares (US$5.5M). The position peaked in Q2 2026 at 75,179 shares, worth US$7.8M. Across 13 filings, Royal Fund Management, LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 86,465 shares valued at US$7.4M — an increase of 11,286 shares quarter over quarter.. Notable position changes include a 1394% increase in Q2 2024 (shares rose 8% over the following quarter), a 100% trim in Q3 2025 (shares rose 6% over the following quarter), a 8830000% increase in Q1 2026 (shares rose 45% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.70K $5.49M New
Q4 2023 5.30K $418.49K Reduce
Q1 2024 4.70K $374.87K Reduce
Q2 2024 70.22K $4.17M Add
Q3 2024 7.40K $465.31K Reduce
Q4 2024 1.40K $62.85K Reduce
Q1 2025 1.40K $93.55K Hold
Q2 2025 1.00K $68.98K Reduce
Q3 2025 1 $835 Reduce
Q4 2025 1 $2 Hold
Q1 2026 88.30K $6.34M Add
Q2 2026 75.18K $7.78M Reduce
Q3 2026 86.47K $7.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has Royal Fund Management, LLC held CVS?

Royal Fund Management, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Royal Fund Management, LLC's current position in CVS?

As of Q3 2026, Royal Fund Management, LLC holds 86.47K shares of CVS (CVS HEALTH CORP), valued at $7.41M, representing 0.68% of its reported portfolio and ranking #46.

Has Royal Fund Management, LLC been buying or selling CVS?

In the latest 13F filing (Q3 2026), Royal Fund Management, LLC increased its position in CVS. The position peaked in Q2 2026 at 75.18K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.